| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +100.00% | -12.76% | +3.20% | -15.96% | -15.96% | — |
| 14d | 4 | +100.00% | -9.23% | +4.20% | -13.43% | -13.43% | — |
| 30d | 4 | +100.00% | -14.51% | +8.49% | -23.00% | -23.00% | — |
| 60d | 4(4 pending) | — | — | — | — | — | — |
| 90d | 4(4 pending) | — | — | — | — | — | — |
| 180d | 4(4 pending) | — | — | — | — | — | — |
| 1y | 4(4 pending) | — | — | — | — | — | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| BLTE BELITE BIO, INC | PURCHASE Chief Financial Officer | 10,000 | — | — | 205,264 | Apr 21, 2026 | Apr 23, 2026 ↗ |
| BLTE BELITE BIO, INC | SALE10b5-1 10b5-1 plan | 291 | $183.08 | $53.3K | 93,800 | Apr 9, 2026 | Apr 13, 2026 ↗ |
| BLTE BELITE BIO, INC | SALE10b5-1 10b5-1 plan | 1,909 | $182.58 | $348.5K | 94,091 | Apr 9, 2026 | Apr 13, 2026 ↗ |
| BLTE BELITE BIO, INC | SALE10b5-1 10b5-1 plan | 2,000 | $181.40 | $362.8K | 96,000 | Apr 9, 2026 | Apr 13, 2026 ↗ |
| BLTE BELITE BIO, INC | SALE10b5-1 10b5-1 plan | 2,000 | $180.35 | $360.7K | 98,000 | Apr 9, 2026 | Apr 13, 2026 ↗ |
| BLTE BELITE BIO, INC | PURCHASEGRANT Stock grant | 144,868 | — | — | 289,736 | Mar 31, 2026 | Apr 2, 2026 ↗ |